UAE Approves Foundayo Pill for Obesity Treatment

Apr 28, 2026

71 min

Apr 28, 2026 09:32

UAE approves Foundayo pill for obesity treatment: What to know

## New Oral Treatment for Obesity

The UAE has approved the Foundayo pill, an innovative oral medication for obesity developed by Eli Lilly and Company. This once-daily pill offers an alternative to injectable therapies, marking a significant advancement in weight management solutions.

## Addressing a Global Health Challenge

Obesity affects over a billion people worldwide and is linked to chronic diseases like type 2 diabetes and heart disease. In the UAE, health authorities are focusing on tackling this issue, recognizing obesity as a complex disease influenced by various factors.

## How Foundayo Works

Foundayo, known scientifically as orforglipron, is part of the GLP-1 receptor agonists class. It helps regulate appetite and metabolism, promoting a feeling of fullness and reducing food intake. Clinical trials have shown promising results, with patients experiencing up to 12.4% weight loss.

## UAE's Proactive Approach

The approval of Foundayo reflects the UAE's commitment to expanding access to advanced obesity treatments. Authorities emphasize that this medication should complement healthy lifestyle habits, not replace them.

## Changing Perceptions of Obesity

Awareness of obesity as a medical condition is growing in the UAE. The introduction of treatments like Foundayo is expected to further shift perceptions, highlighting the need for long-term medical care for obesity.

## Availability

The Foundayo pill is expected to be available to eligible patients in the UAE starting May 2026, providing a new option for those seeking medically supported weight management.

Read the full story at the source

What you need to know to get Emirates ID?

Leave your details and get a guide as a gift to avoid mistakes

Article contents